D.N.A. Biomedical Solutions Aktie
ISIN: IL0011038523
16.05.2022 22:18:27
|
Ginkgo Bioworks Holdings, Inc. Q1 Loss increases, misses estimates
(RTTNews) - Ginkgo Bioworks Holdings, Inc. (DNA) reported Loss for its first quarter that increased from the same period last year and missed the Street estimates.
The company's earnings came in at -$590.5 million, or -$0.37 per share. This compares with -$73.6 million, or -$0.06 per share, in last year's first quarter.
Analysts on average had expected the company to earn -$0.03 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter rose 281.9% to $168.4 million from $44.1 million last year.
Ginkgo Bioworks Holdings, Inc. earnings at a glance (GAAP) :
-Earnings (Q1): -$590.5 Mln. vs. -$73.6 Mln. last year. -EPS (Q1): -$0.37 vs. -$0.06 last year. -Analyst Estimate: -$0.03 -Revenue (Q1): $168.4 Mln vs. $44.1 Mln last year.
-Guidance: Full year revenue guidance: $375-$390 mln

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu D.N.A. Biomedical Solutions Ltd.mehr Nachrichten
Keine Nachrichten verfügbar. |